Literature DB >> 15324461

Monitoring susceptibility to sulfadoxine-pyrimethamine among cases of uncomplicated, Plasmodium falciparum malaria in Saharevo, Madagascar.

L Randrianasolo1, A Randriamanantena, L Ranarivelo, A Ratsimbasoa, O Domarle, M Randrianarivelojosia.   

Abstract

Intermittent preventive treatment (IPT) of pregnant women with sulfadoxine-pyrimethamine (SP) is being considered as a routine practice in Madagascar, mainly to decrease the risks of malaria-associated severe anaemia in the women, and of low birthweight in their babies. There is, however, relatively little information available on the efficacy of SP when used, in Madagascar, to treat cases of Plasmodium falciparum malaria. In a preliminary study, carried out in 2003 in the village of Saharevo, 36 uncomplicated cases were each treated with a standard dose of SP and with paracetamol and then followed up for 28 days. No case of therapeutic failure occurred and all the asexual parasitaemias cleared by day 3. It therefore appears that SP is effective against P. falciparum in Saharevo (and probably in the whole, rural district of Moramanga in which the village lies). This is an encouraging observation to make before IPT is initiated throughout the country.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15324461     DOI: 10.1179/000349804225021398

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  7 in total

1.  Accessible mutational trajectories for the evolution of pyrimethamine resistance in the malaria parasite Plasmodium vivax.

Authors:  Pan-Pan Jiang; Russell B Corbett-Detig; Daniel L Hartl; Elena R Lozovsky
Journal:  J Mol Evol       Date:  2013-09-27       Impact factor: 2.395

2.  First evidence of pfcrt mutant Plasmodium falciparum in Madagascar.

Authors:  Milijaona Randrianarivelojosia; David A Fidock; Olivier Belmonte; Stephanie G Valderramos; Odile Mercereau-Puijalon; Frédéric Ariey
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-01-26       Impact factor: 2.184

3.  Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility.

Authors:  Valérie Andriantsoanirina; Arsène Ratsimbasoa; Christiane Bouchier; Martial Jahevitra; Stéphane Rabearimanana; Rogelin Radrianjafy; Voahangy Andrianaranjaka; Tantely Randriantsoa; Marie Ange Rason; Magali Tichit; Léon Paul Rabarijaona; Odile Mercereau-Puijalon; Rémy Durand; Didier Ménard
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

4.  Drug-resistant malaria parasites introduced into Madagascar from Comoros Islands.

Authors:  Didier Ménard; Armand Eugène Randrianarivo-Solofoniaina; Bedja Said Ahmed; Martial Jahevitra; Valérie Andriantsoanirina; Justin Ranjalahy Rasolofomanana; Léon Paul Rabarijaona
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

5.  Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar.

Authors:  Didier Ménard; Nohary Nina Harimanana Andrianina; Zakaherizo Ramiandrasoa; Arthur Randriamanantena; Noéline Rasoarilalao; Martial Jahevitra; Arsène Ratsimbasoa; Luciano Tuseo; Andrianirina Raveloson
Journal:  Malar J       Date:  2007-05-22       Impact factor: 2.979

6.  Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.

Authors:  Céline Barnadas; Magali Tichit; Christiane Bouchier; Arsène Ratsimbasoa; Laurence Randrianasolo; Rogelin Raherinjafy; Martial Jahevitra; Stéphane Picot; Didier Ménard
Journal:  Malar J       Date:  2008-02-26       Impact factor: 2.979

7.  Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials.

Authors:  Didier Ménard; Arsène Ratsimbasoa; Milijaona Randrianarivelojosia; Léon-Paul Rabarijaona; Lucie Raharimalala; Olivier Domarle; Laurence Randrianasolo; Arthur Randriamanantena; Martial Jahevitra; Valérie Andriantsoanirina; Marie-Ange Rason; Rogelin Raherinjafy; Emma Rakotomalala; Luciano Tuseo; Andrianirina Raveloson
Journal:  Malar J       Date:  2008-04-04       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.